Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Goodwill & Intangibles (2016 - 2025)

ImmunityBio (IBRX) has disclosed Goodwill & Intangibles for 11 consecutive years, with $14.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Goodwill & Intangibles rose 1508.33% to $14.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $14.5 million, a 1508.33% increase, with the full-year FY2023 number at $17.1 million, changed N/A from a year prior.
  • Goodwill & Intangibles was $14.5 million for Q3 2025 at ImmunityBio, up from $900000.0 in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $22.3 million in Q1 2022 to a low of $900000.0 in Q3 2024.
  • A 5-year average of $10.8 million and a median of $14.5 million in 2025 define the central range for Goodwill & Intangibles.
  • Peak YoY movement for Goodwill & Intangibles: decreased 2.94% in 2021, then surged 1508.33% in 2025.
  • ImmunityBio's Goodwill & Intangibles stood at $1.4 million in 2021, then surged by 1341.62% to $20.5 million in 2022, then fell by 16.5% to $17.1 million in 2023, then crashed by 94.73% to $900000.0 in 2024, then skyrocketed by 1508.33% to $14.5 million in 2025.
  • Per Business Quant, the three most recent readings for IBRX's Goodwill & Intangibles are $14.5 million (Q3 2025), $900000.0 (Q3 2024), and $16.6 million (Q1 2024).